Biodexa Pharmaceuticals Stock to Reverse Split on Friday, October 4th (NASDAQ:BDRX)

Shares of Biodexa Pharmaceuticals Plc (NASDAQ:BDRX) are set to reverse split before the market opens on Friday, October 4th. The 1-25 reverse split was announced on Thursday, September 19th. The number of shares owned by shareholders will be adjusted after the closing bell on Thursday, October 3rd.

Biodexa Pharmaceuticals Stock Performance

Shares of NASDAQ:BDRX traded down $0.03 during trading on Wednesday, hitting $0.28. The stock had a trading volume of 998,827 shares, compared to its average volume of 2,405,505. The company has a quick ratio of 1.26, a current ratio of 1.26 and a debt-to-equity ratio of 0.06. Biodexa Pharmaceuticals has a 12 month low of $0.26 and a 12 month high of $8.81. The firm’s fifty day moving average is $0.52 and its 200 day moving average is $0.85.

About Biodexa Pharmaceuticals

Biodexa Pharmaceuticals Plc, a clinical stage biopharmaceutical company, focuses on developing products aimed at primary and metastatic cancers of the brain in the United Kingdom. The company is developing MTX110, which is currently in Phase I studies for the treatment of diffuse intrinsic pontine glioma, medulloblastomas, and glioblastoma multiforme.